Illumina

Yahoo Finance • 10 days ago

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

Illumina has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15% to $140.33 per share while the index has gained 13.3%. Is there a buying opportunity in Illumi... Full story

Yahoo Finance • 14 days ago

Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says

Illumina's (ILMN) mid-teens clinical growth appears sustainable over the next one to two years, driv PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 16 days ago

Trump Lands In China With $16 Trillion Of CEO Power — And One Big Ask For Xi

President Donald Trump landed in China Wednesday for a high-stakes meeting with President Xi Jinping, bringing with him a roster of corporate heavyweights that underscores the market stakes behind the diplomacy. NVDA stock is trading at a... Full story

Yahoo Finance • 17 days ago

Elon Musk To Join Trump On China State Visit. Tesla Stock Sinks.

Tesla CEO Elon Musk will be among a group of business leaders joining President Donald Trump's state visit to China. Continue Reading... Full story

Yahoo Finance • 17 days ago

Here's What Elon Musk Could Discuss In China As He Joins Trump's State Visit

Tesla CEO Elon Musk will be among a group of business leaders joining President Donald Trump's state visit to China. Continue Reading... Full story

Yahoo Finance • 18 days ago

Here's the full list of business executives invited to go with Trump to China

President Donald Trump is set to travel to China this week for a highly anticipated summit with Xi Jinping and has invited CEOs of some of the biggest U.S. companies to join his trip. The CEOs include Tesla's (TSLA [https://seekingalpha.c... Full story

Yahoo Finance • 18 days ago

Tesla's Elon Musk, Apple's Tim Cook among CEOs set to join Trump on China trip

The White House on Monday released a list of 16 top executives invited to join President Trump on his trip to China this week. The president is set to depart Tuesday for Beijing for a series of meetings expected to last through Friday tha... Full story

Yahoo Finance • 27 days ago

ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results exceeding the market’s revenue expectations , with sales up 4.8% year on year to $1.09 billion. The company’s full-year revenue guidance of $4.57 billion at the midpoint ca... Full story

Yahoo Finance • last month

Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Illumina and the Center for Data-Driven Discovery in Biomedicine launched a large pediatric genomic data initiative focused... Full story

Yahoo Finance • 2 months ago

Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration

Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March 18, Illumina and Labcorp (NYSE:LH) ann... Full story

Yahoo Finance • 2 months ago

3 Reasons to Avoid ILMN and 1 Stock to Buy Instead

In a sliding market, Illumina has defied the odds, trading up to $126.99 per share. Its 31.7% gain since October 2025 has outpaced the S&P 500’s 1.8% drop. This was partly due to its solid quarterly results, and the run-up might have inves... Full story

Yahoo Finance • 2 months ago

1 Mid-Cap Stock for Long-Term Investors and 2 We Brush Off

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with... Full story

Yahoo Finance • 2 months ago

Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably involving Tempus AI Inc and Meta Platforms Inc. These trades reflect Ark’s strategic adjustments amidst evolving market conditions and company-specific developments.... Full story

Yahoo Finance • 2 months ago

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 2 months ago

A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

On February 17, 2026, Sessa Capital disclosed a major buy of Sotera Health(NASDAQ:SHC), adding 10,630,381 shares in an estimated $175.80 million trade based on quarterly average pricing. What happened According to a filing with the Secur... Full story

Yahoo Finance • 2 months ago

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Company Logo Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global liquid biopsy product m... Full story

Yahoo Finance • 2 months ago

Illumina Expands Collaboration With Labcorp To Advance Precision Oncology

(RTTNews) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of next-generation sequencing solutions across the healthcare ecosystem. As part o... Full story

Yahoo Finance • 3 months ago

Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Illumina (NasdaqGS:ILMN) expanded its Alliance for Genomic Discovery by adding Regeneron Genetic... Full story

Yahoo Finance • 3 months ago

Illumina (ILMN) Gaining from Stronger Than Expected Results

Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Patient Opportunity Equity Strategy return... Full story

Yahoo Finance • 3 months ago

AI in Biotechnology Market Research and Global Forecast Report 2025-2035: Opportunities Surge Amid Predictive Modeling, Healthcare Breakthroughs and Agricultural, Environmental Advancements

Company Logo Enhanced AI adoption for predictive drug safety analytics, laboratory process automation, and cost-efficient research pipelines are fueling growth. Expansion in biological datasets, cloud infrastructures, and governmental sup... Full story